Complication after organ transplantation

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:306644T86.8
Who is this for?
Show terms as
13Active trials8Specialists8Treatment centers2Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Complications after organ transplantation refer to a range of medical problems that can happen after a person receives a transplanted organ, such as a kidney, liver, heart, lung, or other organ. These complications are not caused by a single gene or inherited condition, but rather arise from the complex interaction between the transplanted organ and the recipient's body. The most common issue is organ rejection, where the body's immune system attacks the new organ because it recognizes it as foreign. To prevent this, patients must take immunosuppressive medications, which lower the immune system's activity. However, these medications can lead to their own set of problems, including increased risk of infections, certain cancers, high blood pressure, diabetes, and kidney damage. Other complications can include problems with blood vessels connected to the transplanted organ, bile duct or airway issues depending on the organ type, and a condition called graft-versus-host disease where immune cells from the donor organ attack the recipient's body. Some patients may also experience a return of the original disease in the new organ. The treatment landscape focuses on carefully balancing immunosuppressive drugs to prevent rejection while minimizing side effects, treating infections promptly, monitoring organ function through regular blood tests and biopsies, and managing any other health problems that arise. With modern medicine, many transplant recipients live long and productive lives, but lifelong medical follow-up is essential.

Key symptoms:

Fever or chillsSwelling or pain near the transplant siteDecreased urine output (for kidney transplants)Fatigue and weaknessUnexplained weight gain from fluid retentionShortness of breathJaundice or yellowing of the skinNausea, vomiting, or diarrheaHigh blood pressureFrequent infectionsSkin changes or new skin growthsTremors or shaking handsJoint pain or muscle achesChanges in blood sugar levelsMood changes or confusion

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Nov 2024Allo HSCT for High Risk Hemoglobinopathies

Masonic Cancer Center, University of Minnesota — PHASE2

TrialRECRUITING
Jul 2024Modified Second Haplo-transplantation for Graft Failure

Peking University People's Hospital — NA

TrialRECRUITING
Jul 2024Second Haplo-transplantation for Graft Failure

Peking University People's Hospital — NA

TrialRECRUITING
Mar 2024Association Between Renal Regional Oxygen Saturation Measured by Near-InfraRed Spectroscopy and Postoperative Renal Failure After Lung Transplantation Surgery: A Pilot Study

Assistance Publique Hopitaux De Marseille

TrialRECRUITING
Mar 2024HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients

University of California, San Francisco — NA

TrialRECRUITING
Dec 2023Early Use of Long-acting Tacrolimus in Lung Transplant Recipients

Vanderbilt University Medical Center — EARLY_PHASE1

TrialRECRUITING
Sep 2023Hepatic Artery Stenosis and Thrombosis After Liver Transplantation in Children

University Medical Center Groningen

TrialENROLLING BY INVITATION
Jun 2023Immunogenicity of HPV Vaccine in Transplant Recipients.

Medical College of Wisconsin — PHASE4

TrialACTIVE NOT RECRUITING
Jul 2022Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

The Methodist Hospital Research Institute — PHASE2

TrialENROLLING BY INVITATION
Apr 2022Angiotensin 2 for AKI After OLT

University of California, Los Angeles — PHASE4

TrialENROLLING BY INVITATION

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Complication after organ transplantation.

13 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

13 recruitingView all trials with filters →
Phase 42 trials
Immunogenicity of HPV Vaccine in Transplant Recipients.
Phase 4
Active
PI: Denise Uyar, MD (Medical College of Wisconsin/ Froedtert Hospital) · Sites: Milwaukee, Wisconsin · Age: 1845 yrs
Angiotensin 2 for AKI After OLT
Phase 4
Enrolling by Invitation
· Sites: Los Angeles, California · Age: 1899 yrs
Phase 23 trials
A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases
Phase 2
Actively Recruiting
PI: Glen Lew (Pierre Fabre Laboratories) · Sites: Los Angeles, California; Orange, California +38 more
Allo HSCT for High Risk Hemoglobinopathies
Phase 2
Actively Recruiting
· Sites: Minneapolis, Minnesota · Age: 055 yrs
Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation
Phase 2
Enrolling by Invitation
· Sites: Houston, Texas · Age: 1865 yrs
N/A3 trials
Modified Second Haplo-transplantation for Graft Failure
N/A
Actively Recruiting
PI: Xiao-Jun Huang, M.D. (Institute of Hematology, Peking University People') · Sites: Beijing, Beijing Municipality · Age: 1499 yrs
HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients
N/A
Actively Recruiting
PI: Sharad Wadhwani, MD, MPH (University of California, San Francisco) · Sites: San Francisco, California; Atlanta, Georgia · Age: 1825 yrs
Second Haplo-transplantation for Graft Failure
N/A
Actively Recruiting
PI: Xiao-Jun Huang, M.D. (Institute of Hematology, Peking University People') · Sites: Beijing, Beijing Municipality · Age: 1499 yrs
Other4 trials
Highly Suppressive Treg in Delayed and Slow Graft Function After Kidney Transplantation
Active
PI: Henry Randall, MD (St. Louis University) · Sites: San Bernardino, California; St Louis, Missouri · Age: 1899 yrs
Association Between Renal Regional Oxygen Saturation Measured by Near-InfraRed Spectroscopy and Postoperative Renal Failure After Lung Transplantation Surgery: A Pilot Study
Actively Recruiting
PI: François CREMIEUX (Assistance Publique Hopitaux De Marseille) · Sites: Marseille · Age: 1899 yrs
NRP vs DHOPE vs COR-NMP in ECD-DCD Donation
Actively Recruiting
PI: Jeroen de Jonge, Dr. (Erasmus Medical Center) · Sites: Rotterdam, South Holland · Age: 5075 yrs
Hepatic Artery Stenosis and Thrombosis After Liver Transplantation in Children
Enrolling by Invitation
· Sites: Groningen · Age: 018 yrs

Specialists

8 foundView all specialists →
FC
Federica Cattaneo
Specialist
PI on 1 active trial5 Complication after organ transplantation publications
JD
Jeroen de Jonge, Dr.
Specialist
PI on 1 active trial
DM
Denise Uyar, MD
MILWAUKEE, WI
Specialist
PI on 2 active trials
ET
Ephraim S Tang
PORTLAND, OR
Specialist
PI on 1 active trial
GS
Gunnar Söderdahl
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

2 resources

Mycophenolate Mofetil, mycophenolate mofetil

Roche

Organ Transplant

Unverified — confirm before calling
copay card
Copay CardPatient Assistance
Accepting applications

MYCOPHENOLATE MOFETIL

Roche

Organ Transplant

Unverified — confirm before calling
copay card
Copay CardPatient Assistance
Accepting applications

Travel Grants

No travel grants are currently matched to Complication after organ transplantation.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Complication after organ transplantationForum →

No community posts yet. Be the first to share your experience with Complication after organ transplantation.

Start the conversation →

Latest news about Complication after organ transplantation

Disease timeline:

New recruiting trial: A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases

A new clinical trial is recruiting patients for Complication after organ transplantation

New recruiting trial: NRP vs DHOPE vs COR-NMP in ECD-DCD Donation

A new clinical trial is recruiting patients for Complication after organ transplantation

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What type of rejection am I most at risk for, and how will you monitor for it?,What are the side effects of my immunosuppressive medications, and what should I report immediately?,How often will I need blood tests and follow-up visits?,Are there any foods, drinks, or over-the-counter medications I need to avoid?,What signs of infection should I watch for, and when should I go to the emergency room?,How will my cancer risk be monitored over time?,When can I return to work, school, or physical activities?

Common questions about Complication after organ transplantation

What is Complication after organ transplantation?

Complications after organ transplantation refer to a range of medical problems that can happen after a person receives a transplanted organ, such as a kidney, liver, heart, lung, or other organ. These complications are not caused by a single gene or inherited condition, but rather arise from the complex interaction between the transplanted organ and the recipient's body. The most common issue is organ rejection, where the body's immune system attacks the new organ because it recognizes it as foreign. To prevent this, patients must take immunosuppressive medications, which lower the immune syst

How is Complication after organ transplantation inherited?

Complication after organ transplantation follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Are there clinical trials for Complication after organ transplantation?

Yes — 13 recruiting clinical trials are currently listed for Complication after organ transplantation on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Complication after organ transplantation?

8 specialists and care centers treating Complication after organ transplantation are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.

What treatment and support options exist for Complication after organ transplantation?

2 patient support programs are currently tracked on UniteRare for Complication after organ transplantation. See the treatments and support programs sections for copay assistance, eligibility, and contact details.